CVS Health Corporation (NYSE:CVS) and Express Scripts Holding Company (NYSE:ESRX) are both Healthcare companies that recently hit new low. Many investors are wondering what to do with these names trading at such extreme levels. To determine if one is a better investment than the other, we will compare the two across growth, profitability, risk, return, dividends, and valuation measures.CVS Health Corporation (NYSE:CVS) operates in the Health Care Plans segment of the Healthcare sector. The company has grown sales at a 10.60% annual rate over the past five years, putting it in the high growth category. CVS has a net profit margin of 2.80% and is more profitable than the average company in the Health Care Plans industry. In terms of efficiency, CVS has an asset turnover ratio of 2.02. This figure represents the amount of revenue a company generates per dollar of assets. CVS’s financial leverage ratio is 1.38, which indicates that the company’s asset base is primarily funded by equity capital. Company’s return on equity, which is really just the product of the company’s profit margin, asset turnover, and financial leverage ratios, is 14.40%, which is better than the Health Care Plans industry average ROE.CVS Health Corporation (CVS) pays out an annual dividend of 2.00 per share. At the current valuation, this equates to a dividend yield of 2.84%. The company has a payout ratio of 39.60%. CVS’s current dividend therefore should be sustainable. Stock’s free cash flow yield, which represents the amount of cash available to investors before dividends, expressed as a percentage of the stock price, is 2.2. All else equal, companies with higher FCF yields are viewed as cheaper. Company trades at a P/E ratio of 14.53 , and is less expensive than the average stock in the Health Care Plans industry. The average investment recommendation for CVS, taken from a group of Wall Street Analysts, is 2.20, or a buy.Over the past three months, CVS Health Corporation insiders have been net buyers, dumping a net of -703,801 shares. This implies that insiders have been feeling relatively bearish about the outlook for CVS. Insider activity and sentiment signals are important to monitor because they can shed light on how “risky” a stock is perceived to be at it’s current valuation. Knowing this, it makes sense to look at beta, a measure of market risk. CVS has a beta of 0.86 and therefore an below average level of market volatility.
     (adsbygoogle = window.adsbygoogle || []).push({});
Express Scripts Holding Company (NASDAQ:ESRX) operates in the Health Care Plans segment of the Healthcare sector. ESRX has increased sales at a 16.80% CAGR over the past five years, and is considered a high growth stock. The company has a net profit margin of 3.60% and is more profitable than the average Health Care Plans player. ESRX’s asset turnover ratio is 1.95 and the company has financial leverage of 1.41. ESRX’s return on equity of 22.70% is better than the Health Care Plans industry average.Stock has a payout ratio of 0.00%. According to this ratio, ESRX should be able to continue making payouts at these levels. The company trades at a free cash flow yield of 5.17 and has a P/E of 10.12. Compared to the average company in the 21.40 space, ESRX is relatively cheap. The average analyst recommendation for ESRX is 2.90, or a hold.Express Scripts Holding Company insiders have bought a net of 12,880 shares during the past three months, which implies that the company’s top executives have been feeling bullish about the stock’s outlook. Finally, ESRX’s beta of 0.85 indicates that the stock has an below average level of market risk.CVS Health Corporation (NASDAQ:ESRX) scores higher than Express Scripts Holding Company (NYSE:CVS) on 8 of the 13 measures compared between the two companies. ESRX has the better fundamentals, scoring higher on growth, profitability and return metrics. ESRX wins on valuation measures. ESRX has better insider activity and sentiment signals.



(adsbygoogle = window.adsbygoogle || []).push({});




(adsbygoogle = window.adsbygoogle || []).push({});




(adsbygoogle = window.adsbygoogle || []).push({});


Economy and Money Authors gives investors their free and unbiased view of Financial Markets and on what happening in Stock Market. Our team certainly analyze tons of Stocks every day and provide their fair opinion on them. We are always looking over financial statements, company’s earning, analyst upgrades/downgrades, joint ventures and balance sheets to keep our reader up to date.